Professor Lola Eniola-Adefeso is the University Diversity and Social Transformation Professor of Chemical Engineering and Biomedical Engineering at the University of Michigan. She has 20+ years’ research experience in neutrophil mechanisms in acute and chronic inflammatory diseases and is an expert on vascular-targeted nano/microparticle technologies for disease treatment. She is a Fellow of the American Institute of Medical and Biological Engineering (AIMBE). She is serving as CTO of Asalyxa, a recently launched start-up company, to develop particle technology for combating neutrophilic injury.